RPRX
Royalty Pharma Plc
58.40$
+0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.9% | 28.1% | 28.7% | 25.9% | 22.9% | 6.7% | 12.8% | 16.4% | 15.2% | 7.8% | 9.9% | 3.2% | |
| 99.3% | 15.9% | 16.0% | 12.1% | 16.9% | 2.0% | 4.8% | 8.8% | 10.2% | 2.9% | 5.1% | 3.2% | |
| – | 15.9% | 16.0% | 12.1% | 21.0% | 6.4% | 9.4% | 16.0% | 14.4% | 7.5% | 9.7% | 3.2% | |
| – | – | – | – | 1.7% | 0.3% | 0.2% | 0.4% | 0.2% | 0.1% | 0.1% | 4.5% | |
| – | – | – | – | 0.2% | – | 3.1% | 0.0% | 0.0% | – | – | – | |
| 0.1% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 0.0% | 4.7% | |
| – | 64.3% | – | – | 0.7% | 0.4% | 0.1% | 0.0% | 0.1% | 0.0% | 83.0% | – | |
| 6.2% | 56.6% | 57.5% | 60.7% | 60.0% | 50.7% | 29.0% | 41.5% | 43.3% | 38.4% | 43.2% | 50.5% | |
| 6.2% | 2.9% | 2.8% | 3.4% | 5.1% | 2.7% | 1.5% | 1.0% | 6.9% | 1.0% | 6.9% | 3.2% | |
| – | 1.7% | 1.6% | 2.5% | 2.5% | 2.3% | 1.3% | 39.3% | 5.9% | – | 5.5% | 1.9% | |
| 4.5% | 0.0% | 0.0% | – | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | |
| – | – | – | – | 54.9% | 47.8% | 27.6% | 40.5% | 36.4% | 37.5% | 36.3% | 43.7% | |
| 93.8% | 43.2% | 42.4% | 39.2% | 39.5% | 49.0% | 71.0% | 58.5% | 33.5% | 39.8% | 38.1% | 33.0% | |
| -581.7% | -2.8% | -3.0% | – | 10.7% | 22.7% | 9.1% | 12.9% | 11.7% | 15.4% | 15.6% | 12.0% | |
| 754.5% | 5.6% | 5.8% | 3.1% | 3.1% | 2.8% | 1.8% | 2.4% | 3.4% | 3.7% | 3.3% | 2.9% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.